Press-release for stocks publishing date 2021 - 05

Prices are updated after-hours

VistaGen Therapeutics Announces Appointment of Ann Cunningham as Chief Commercial Officer
Published: 2021-05-04 (Crawled : 12:00) - globenewswire.com
LLY | News | $732.2 -1.81% -0.71% 8K

| 304.59% | O: 0.87% H: 1.36% C: 0.36%
VTGN | $4.64 -1.7% 38K

| 77.44% | O: 1.13% H: 0.0% C: -3.72%
commercialization

Faze Medicines Appoints Douglas Kerr, M.D., Ph.D., to its Board of Directors
Published: 2021-05-04 (Crawled : 12:00) - biospace.com/
LLY | News | $732.2 -1.81% -0.71% 8K

| 304.59% | O: 0.87% H: 1.36% C: 0.36%

PFIZER REPORTS STRONG FIRST-QUARTER 2021 RESULTS
Published: 2021-05-04 (Crawled : 12:00) - biospace.com/
VTRS | News A | $11.585 0.3% 150K

| -14.44% | O: -0.07% H: 1.11% C: -0.67%
PFE | News 4 | $26.27 -0.19% -0.38% 130K

| -34.04% | O: 0.43% H: 0.43% C: -0.13%
LLY | News | $732.2 -1.81% -0.71% 8K

| 304.59% | O: 0.87% H: 1.36% C: 0.36%
BNTX | News | $87.62 -0.53% 29K

| -57.83% | O: 1.72% H: 0.31% C: -16.76%
results report

| -85.0% | O: -0.65% H: 10.38% C: 8.4%
LLY | News | $732.2 -1.81% -0.71% 8K

| 304.59% | O: 0.87% H: 1.36% C: 0.36%
covid clinical trials antibody trial covid-19

Lilly Outlines Robust Plans to Strengthen ESG Commitments Across the Globe
Published: 2021-05-04 (Crawled : 12:00) - biospace.com/
LLY | News | $732.2 -1.81% -0.71% 8K

| 304.59% | O: 0.87% H: 1.36% C: 0.36%